Corona plasma modification of polyamide 66 for the design of textile delivery systems for Cosmetic therapy

Applied Surface Science

Volumn 316, Issue 1, 2014, Pages 251-258

  Labay, C ^a   Canal, J M ^a   Navarro, A ^a   Canal, C ^a,b  

^a UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Caffeine release; Corona plasma treatment; Drug delivery system; Fibers; Polyamide 6.6; Surface functionalization

Indexed keywords

CAFFEINE; CHEMICAL MODIFICATION; COSMETICS; FIBERS; MEDICAL APPLICATIONS; PLASMA APPLICATIONS; SURFACE TREATMENT; TARGETED DRUG DELIVERY; TEMPERATURE; TEXTILE FIBERS; TEXTILE FINISHING; TEXTILES; WETTING;

ACTIVE INGREDIENTS; CORONA PLASMAS; DRUG DELIVERY SYSTEM; LOW TEMPERATURE PLASMAS; POLYAMIDE 6.6; SURFACE FUNCTIONALIZATION; TECHNICAL TEXTILES; TOPOGRAPHICAL PROPERTIES;

CONTROLLED DRUG DELIVERY;

EID: 84922509883     PISSN: 01694332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apsusc.2014.07.191     Document Type: Article

References (41)

1. G. Madar, L. K. Widmer, E. Zemp, M. Maggs, Varicose veins and chronic venous insufficiency disorder or disease? A critical epidemiological review, Vasa 15 (1986) 126-134.
2. M. J. Callam, Prevalence of chronic leg ulceration and severe chronic venous disease in western countries, Phlebologie 7 (1992) 6-12.
3. M. J. Callam, Epidemiology of varicose veins, Br. J. Surg. 81 (1994) 167-173.
4. X. Kurz, D. L. Lamping, S. R. Kahn, U. Baccaglini, F. Zuccarelli, G. Spreafico, Do varicose veins affect quality of life? Results of an international populationbased study, J. Vasc. Surg. 34 (2001) 641-648.
5. R. M. Kaplan, M. H. Criqui, J. O. Denenberg, J. Bergan, A. Fronek, Quality of life in patients with chronic venous disease: San Diego population study, J. Vasc. Surg. 37 (2003) 1047-1153.
6. M. P. Goldman, P. A. Bacci, G. Leibaschoff, D. Hexsel, F. Angelini, Cellulite Pathophysiology and Treatment, Taylor & Francis, New York, 2001.
7. J. M. Ritchie, The Xanthines. The Pharmacological Basis of Therapeutics, 5th ed., MacMillan, New York, 1975, pp. 367.
8. J.-W. Yun, E.-S. Shin, S.-Y. Cho, S.-H. Kim, C.-W. Kim, T.-R. Lee, B.-H. Kim, The effects of BADGE and caffeine on the time-course response of adiponectin and lipid oxidative enzymes in high fat diet-fed C57BL/6J mice: correlation with reduced adiposity and steatosis, Exp. Anim. 57 (2008) 461-469.
9. A. Liguori, Absorption and subjective effects of caffeine from coffee, cola and capsules, Pharm. Biochem. Behav. 58 (1997) 721-726.
10. R. J. Batchelder, R. J. Calder, C. P. Thomas, C. M. Heard, In vitro transdermal delivery of the major catechins and caffeine from extract of Camellia sinensis, Int. J. Pharm. 283 (2004) 45-51.
11. M. A. Bolzinger, S. Briancon, J. Pelletier, H. Fessi, Y. Chevalier, Percutaneous release of caffeine from microemulsion, emulsion and gel dosage forms, Eur. J. Pharm. Biopharm. 68 (2008) 446-451.
12. P. Monllor, M. A. Bonet, F. Cases, Characterization of the behaviour of fragrance microcapsules in cotton fabric, Eur. Polym. J. 43 (2007) 2481-2490.
13. S. Beauge Duguet, Skin'Up, Patent WO 08/068418, 2008.
14. H. S. Yoo, T. G. Kim, T. G. Park, Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery, Adv. Drug Deliv. Rev. 61 (2009) 1033-1042.
15. T. Okuda, K. Tominaga, S. Kidoaki, Time-programmed dual release formulation by multilayered drug-loaded nanofiber meshes, J. Control. Release 143 (2010) 258-264.
16. C. Labay, C. Canal, M. J. García-Celma, Influence of corona treatment on plasma PPand PA 6.6 on the release of a model drug, Plasma Chem. Plasma Process. 30 (2010) 885-896.
17. R. Shishoo, Plasma Technologies for Textiles, 1st ed., Woodhead Publishing Limited, Cambridge, 2007.
18. M. Morra, E. Occhiello, F. Garbassi, Contact angle hysteresis in oxygen plasma treated poly (tetrafluoroethylene), Langmuir 5 (1989) 872-876.
19. A. Patiño, C. Canal, C. Rodríguez, G. Caballero, A. Navarro, J. M. Canal, Surface and bulk cotton fibre modifications: plasma and cationization: influence on dyeing with reactive dye, Cellulose 18 (2011) 1073-1083.
20. C. Labay, J. M. Canal, C. Canal, Relevance of surface modification of PA 6.6 fibers by air plasma treatment on the release of caffeine, Plasma Process. Polym. 9 (2012) 165-173.
21. J. D. Bos, M. M. Meinardi, The 500 Dalton rule forthe skin penetration of chemical compounds and drugs, Exp. Dermatol. 9 (2000) 165-169.
22. M. B. Brown, G. P. Martin, S. A. Jones, F. K. Akomeah, Dermal and transdermal drug delivery systems: current and future prospects, Drug Deliv. 13 (2006) 175-187.
23. J. Nakamatsu, L. F. Delgado-Aparicio, R. Da Silva, F. Soberón, Ageing of plasmatreated poly (tetrafluoroethylene) surfaces, J. Adhes. Sci. Technol. 13 (1999) 753-761.
24. R. Molina, P. Jovancic, D. Jocic, E. Bertran, P. Erra, Surface characterization of keratin fibres treated by water vapour plasma, Surf. Interface Anal. 35 (2003) 128-135.
25. C. Canal, R. Molina, E. Bertran, P. Erra, Wettability, ageing and recovery process of plasma treated polyamide 6, J. Adhesion Sci. Technol. 18 (2004) 1077-1089.
26. C. Canal, R. Molina, E. Bertan, A. Navarro, P. Erra, Effects of low temperature plasma on wool and wool/nylon blend dyed fabrics, Fiber. Polym. 9 (2008) 293-300.
27. R. Morent, N. De Geyter, J. Verschuren, K. De Clerck, P. Kiekens, C. Leys, Non-thermal plasma treatment of textiles, Surf. Coat. Technol. 202 (2008) 3427-3449.
28. C. Washington, Drug release from microdisperse systems: a critical review, Int. J. Pharm. 58 (1990) 1-12.
29. T. Bahners, The "dos" and "don'ts" of wettability characterization in textiles, J. Adh. Sci. Technol. 25 (2011) 2005-2021.
30. K. H. Kale, A. N. Desai, Atmospheric pressure plasma treatment of textiles using non-polymerizing gases, Indian J. Fibre Text. 36 (2011) 289-299.
31. T. J. Sill, H. A. von Recum, Electrospinning applications in drug delivery and tissue engineering, Biomaterials 29 (2008) 1989-2006.
32. E. Valarezo, L. Tamaro, S. Gonzalez, O. Malagon, V. Vittoria, Fabrication and sustained release properties of poly ((-caprolactone) electrospun fibers loaded with layered double hydroxide nanoparticles intercalated with amoxicillin, Appl. Clay Sci. 72 (2013) 104-109.
33. A. W. Hixon, J. H. Crowell, Dependence of reaction velocity upon surface and agitation (I) theoretical consideration, Ind. Eng. Chem. 23 (1931) 923-931.
34. T. Higuchi, Rate of release of medicaments from ointment bases containing drugs in suspension, J. Pharm. Sci. 50 (1961) 874-875.
35. T. Higuchi, Mechanism of sustained action medication theoretical analysis of rate of release of solid drugs dispersed in solid matrices, J. Pharm. Sci. 52 (1963) 1145-1149.
36. M. Gibaldi, S. Feldman, Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms, J. Pharm. Sci. 56 (1967) 1238-1242.
37. J. G. Wagner, Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules, J. Pharm. Sci. 58 (1969) 1253-1257.
38. F. Langenbucker, Linearization of dissolution rate curves by the Weibull distribution, J. Pharm. Pharmacol. 24 (1972) 979-981.
39. J. A. Goldsmith, N. Randall, S. D. Ross, On methods of expressing dissolution rate data, J. Pharm. Pharmacol. 30 (1978) 347-349.
40. P. L. Ritger, N. A. Peppas, A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, J. Control. Release 5 (1987) 23-36.
41. R. A. Siegel, M. J. Rathbone, in: J. Siepmann, et al. (Eds.), Controlled Release Mechanisms in Fundamentals and Applications of Controlled Release Drug Delivery, Advances in Delivery Science and Technology, Controlled Release Society, 2012.